FIT Board Review Corner April 2017

Similar documents
Middleton Chapter 42b (pages ): Allergic and Nonallergic Rhinitis Prepared by: Tammy Peng, MD

Middleton Chapter 43 (pages ) Rhinosinusitis and Nasal Polyps Prepared by: Malika Gupta, MD

How to Successfully Manage Chronic Urticaria? & Tall Tales from Texas

Urticaria. Appearance. Epidemiology [1] Aetiology [2]

They re Scratching and You re Scratching Your Head: An Approach to the Diagnosis and Management of Acute and Chronic Urticaria

4/12/18. Refractory Chronic Urticaria: When Omalizumab Fails. Objectives. Disclosures

Managing urticaria in primary care

PedsCases Podcast Scripts

Update on urticaria Associate Professor Rohan Ameratunga Adapted for New Zealand from GLORIA Module 12: Urticaria

Chapter 65 Allergy and Immunology for the Internist. ingestion provoke an IgE antibody response and clinical symptoms in sensitive individuals.

Do My Patient s Hives Always = Allergy? Julie Sterbank, DO Allergy & Immunology MetroHealth Medical Center

Urticaria and Angioedema

COMMISSIONING POLICY RECOMMENDATION TREATMENT ADVISORY GROUP Policy agreed by North Lincolnshire CCG November 2012

Agroup as large as 15% to 24% of

CHRONIC URTICARIA; IT S MORE THAN JUST ANTIHISTAMINES!

Mast Cell Mediators. Updates on Chronic Urticaria 11/1/2016. Urticaria: What happens in the skin?

Perspectives in Primary Care: Evaluating and Managing Patients With Chronic Urticaria

Urticaria. An Evidence-Based Approach to Diagnosis & Management. July 16, 2015 Walter E. Washington Convention Center. Educational partner RMEI, LLC

Department of Paediatrics Clinical Guideline URTICARIA GUIDELINE BACKGROUND

--Manuscript Draft-- World Allergy Organization Position Paper (Provisional) Centro Medico-Docente La Trinidad Caracas, Miranda VENEZUELA

We are IntechOpen, the first native scientific publisher of Open Access books. International authors and editors. Our authors are among the TOP 1%

The proposal is to add text/statements in red and to delete text/statements with strikethrough: POLICY

Itch and Swelling update: Practical Approach to Urticaria & Angioedema

Perspectives in Primary Care: Evaluating and Managing Patients with Chronic Urticaria

REFERRAL GUIDELINES - SUMMARY

Annual Rheumatology & Therapeutics Review for Organizations & Societies

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Single Technology Appraisal (STA)

Allergy Medicine James MacLean, M.D.

Urticaria and Angioedema. Allergy and Immunology Awareness Program

Allergy Medicine James MacLean, M.D.

Diagnosis and Treatment of Urticaria and Angioedema: A Worldwide Perspective

xx Xolair 150 MG SOLR (GENENTECH)

Acute and Chronic Urticaria, Including New Treatment Options

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE

Topic 9 (Ch16_18) Immune Disorders. Allergies. 4 Hypersensitivity Types. Topics - Allergies - Autoimmunity - Immunodeficiency

Current Concepts in the Pathogenesis and Management of Urticaria and Angioedema:

Familial atypical cold urticaria: Description of a new hereditary disease

=ﻰﻤاﻤﺤﻠا ﺔﻴﻘﻠﺤﻠا ﺔذﺒاﻨﻠا

Hypersensitivity is the term used when an immune response results in exaggerated or inappropriate reactions harmful to the host.

Sporadic Antihistamine-Resistant Angioedema Potential Pathophysiological Mechanisms

What the first 10,000 patients with chronic urticaria have taught me: A personal journey

2012/12/5. Principle of the management of urticaria. The efficacy of systemic steroid on urticaria depends of subtypes urticaria

Anaphylaxis: The Atypical Varieties

Treatment Options for Refractory Urticaria

Xolair. Xolair (omalizumab) Description

Xolair. Xolair (omalizumab) Description

Disclosures. Objectives 1/27/13. Pinkus Goldberg MD, FAAAAI, FAACAI, CPI Karen Rance DNP, RN, CPNP, AE-C. Allergy Partners of Central Indiana

Allergy & Urticaria. James MacLean, M.D.

Cigna Drug and Biologic Coverage Policy

Clinical and Experimental Allergy

Allergic Conditions in Sports. Seth Smith, MD, CAQ-SM, PharmD TPC Course February 7, 2016


Evaluation, diagnosis and management of chronic urticaria

Managing Penicillin Allergy

The management of chronic urticaria in primary care for adults and children

TREATMENT OF ALLERGIC SKIN DISEASES

Clinico - etiological study of chronic Urticaria and the role of autologous serum skin test in the diagnosis of chronic idiopathic Urticaria

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Autoimmunity and autoinflammation

Chronic urticaria (CU) is a debilitating skin condition

Clinical Policy Title: Omalizumab for the treatment of chronic idiopathic urticaria

Allergic rhinitis (Hay fever) Asthma Anaphylaxis Urticaria Atopic dermatitis

3302: Therapy Options for Patients with Anti-Histamine Resistant Chronic Urticaria

Xolair (Omalizumab) Drug Prior Authorization Protocol (Medical Benefit & Part B Benefit)

Drug allergy and Skin Disorders. Timothy Craig, DO, FACOI Professor of Medicine and Pediatrics Distinguished Educator Penn State University, Hershey

Coverage Criteria: Express Scripts, Inc. monograph dated 03/03/2010

Allergy and inflammation

Lecture 03: Drug allergy

URTICARIA. Roundtable session

Idiopathic U rticaria U Urticaria Diffuse Giant Hives

Pharmacotherapy for Allergic Rhinitis

Path2220 INTRODUCTION TO HUMAN DISEASE ALLERGY. Dr. Erika Bosio

Autologous serum skin test versus histamine release test in the diagnosis of Chronic autoimmune urticaria

Acute urticaria in children - management. Clive Grattan St John s Institute of Dermatology, London Norfolk & Norwich University Hospital

Omalizumab (Xolair) NHLBI normal ranges by age for FEV 1/FVC 8-19 years of age 85%; years of age 80%;

Management of Chronic Idiopathic Urticaria

Management of urticaria: Iranian Society of Dermatology clinical practice guideline

Chapter 10 (pages ): Differentiation and Functions of CD4+ Effector T Cells Prepared by Kristen Dazy, MD, Scripps Clinic Medical Group

Questions. Answers. Share your photos and diagnoses with us!

S003 CPC Self-Assessment

CHRONIC URTICARIA IN CHILDREN: A REVIEW

Immunology. Lecture- 8

XOLAIR (omalizumab) Prior Authorization

CPC. Chutika Srisuttiyakorn, M.D. Kobkul Aunhachoke, M.D. Phramongkutklao Hospital Bangkok, Thailand

Urticaria: The final common pathway

PedsCases Podcast Scripts

ALLERGIC RHINOSINUSITIS. Sirisha A Post graduate Dept of Pharmacology Kamineni Institute of Medical Sciences

How the Innate Immune System Profiles Pathogens

Allergy overview. Mike Levin Division of Asthma and Allergy Department of Paediatrics University of Cape Town Red Cross Hospital

Itchy, Scratchy, Red and Patchy: Derm tips for primary care. Robert Gniadecki, MD

While many people believe they may be allergic

Pediatric Dermatology

Urticaria diagnosis and management

Immunologic Mechanisms of Tissue Damage. (Immuopathology)

Allergy and Immunology Review Corner: Chapter 57 of Middleton s Allergy Principles and Practice, 7 th Edition, edited by N. Franklin Adkinson, et al.

Allergy & Urticaria Workshop James MacLean, M.D.

Supplementary Online Content

Cutaneous Adverse Drug Reactions in Domestic Animals. Katherine Doerr, DVM, Dip. ACVD. Veterinary Dermatology Center

OBJECTIVES DEFINITION TYPE I HYPERSENSITIVITY TYPES OF HYPERSENSITIVITY ACUTE ALLERGIC REACTION 11/5/2016

Hien Nguyen Reeves, MD, ABAI, ABIM Clinical instructor UBC, Kelowna, BC

Transcription:

FIT Board Review Corner April 2017 Welcome to the FIT Board Review Corner, prepared by Tammy Peng, MD, and Amar Dixit, MD, senior and junior representatives of ACAAI's Fellows-In-Training (FITs) to the Board of Regents. The FIT Board Review Corner is an opportunity to help hone your Board preparedness. Review Questions Allergy and Immunology Review Corner: Middleton s Allergy Principles and Practice, 8th Edition N. Franklin Adkinson Jr., MD, Bruce S Bochner, MD, A Wesley Burks, MD, William W Busse, MD, Stephen T Holgate, MD, DSc, FMedSci, Robert F Lemanske, Jr., MD and Robyn E O'Hehir, FRACP, PhD, FRCPath Chapter 36 (pages 579-583): Urticaria and angioedema Prepared by: Tammy Peng, MD 1. Which of the following characteristics are more consistent with urticarial vasculitis? a. Lesions are pruritic and raised in appearance. b. Lesions are painful, last longer than 48 hours and may leave purpura or ecchymosis. c. Lesions may be erythematous with central pallor. d. Lesions are more common in areas in which there is compression or friction of the skin. 2. Which condition is characterized by fever, urticarial and monoclonal gammopathy? a. Mastocytosis b. Cryoglobulinemia c. Muckle-Wells syndrome d. Schnitzler syndrome 3. Which of the following represents the most effective, first-line treatment for chronic urticaria? a. Second-generation H1 antihistamine (cetirizine, fexofenadine, loratadine) b. Corticosteroids c. H2 blocker d. First-generation H1 antihistamine (diphenhydramine, hydroxyzine) 4. Which of the following characteristics is typical of polymorphic eruption of pregnancy (PEP), also called pruritic urticarial papules and plaques of pregnancy (PUPPP)? a. Rash involves the face, palms and soles. b. Urticarial lesions that occur around the umbilicus. c. Lesions are triggered by pressure applied to the skin. d. Rash begins as papules within abdominal striae and spreads to involve the extremity.

Page 2 of 5 5. Which of the following histamine-release associated features is seen in a chronic idiopathic urticarial (CIU) responder? a. 10% of cellular histamine content is released to optimal dose of cross-linking anti-ige b. Syk same as or below normal c. Reduced SH2 domain-containing inositol 5-phosphatase (SHIP)-1 levels d. Tenfold higher dose response to anti-ige in active disease e. Increased SH2 domain-containing inositol 5-phosphatase (SHIP)-2 levels 6. Skin biopsy of a lesion demonstrating a predominance of neutrophils consistent with neutrophilic urticaria would be seen in which disease? a. Hereditary autoinflammatory fever syndromes b. Chronic idiopathic urticaria c. Aquagenic Urticaria d. Dermatographism 7. Which of the following is the most common cause of chronic urticaria? a. Food allergies b. Physical urticaria c. Idiopathic urticaria d. Malignancy 8. Which of the following medications that can be used as an alternative therapy in antihistamine refractory chronic urticarial is preferred in urticarial vasculitis, delayed pressure urticarial and angioedema? a. Sulfasalazine b. Dapsone c. Omalizumab d. Calcineurin inhibitors (cyclosporine, tacrolimus) 9. Which of the following systemic diseases associated with urticarial lesions involves a mutation in cryopyrin? a. Mastocytosis b. Cryoglobulinemia c. Familial cold autoinflammatory syndrome d. Muckle-Wells syndrome

Page 3 of 5 10. A 42-year-old woman presents to clinic with a two-month history of recurrent, pruritic rash. She reports that the rash usually develops in the evening often under the waistband of her pants. She also notes that she often has this same itchy rash on her shoulder after carrying her purse around for a few hours. What type of physical urticaria is most consistent with this patient s history? a. Cholinergic urticaria b. Pressure-related urticaria c. Solar urticaria d. Vibratory urticaria

Page 4 of 5 Answers 1. B, pages 579 & 582. Skin lesions that are painful, that last more than 48 hours and that leave residual skin changes including ecchymosis are more suspicious for urticarial vasculitis. Eliciting a history with the presence of such lesions should prompt consideration for skin biopsy. 2. D, page 582. Schnitzler syndrome is a rare systemic disorder in patients with monoclonal IgM or IgG (monoclonal gammopathy). Patients have associated symptoms of fever, weight loss, bone pain, adenopathy and urticaria thought to be secondary circulating immune complexes and complement activation. 3. A, page 582. The most effective, first-line therapy for chronic urticarial is the use of new-generation antihistamines which include fexofenadine, loratadine and cetirizine. These medications are nonsedating, alleviate pruritus and reduce occurrence of wheals. Other options if these agents are only partial effective, one can consider 1) increasing the dose of the nonsedating antihistamine 2) addition of a sedating, oldergeneration antihistamine (diphenhydramine, hydroxyzine) 3) addition of H2 blocker 4) trial of a leukotriene pathway inhibitor. 4. D, page 583. Polymorphic eruption of pregnancy (PEP), also called pruritic urticarial papules and plaques of pregnancy (PUPPP) is a pruritic dermatitis that affects pregnant women. Typically, dermatitis begins as erythematous papules within abdominal striae with periumbilical sparing that then spread to the extremities and coalesce into urticarial plaques. Lesions can be target-like and usually spare the face, palms and soles. Of note, because of limited safety data, only loratadine and cetirizine are currently recommended for use in pregnancy. 5. C, page 579, table 36-2. Blood basophil IgE receptor responses in patients with chronic idiopathic urticarial (CIU) have been divided into two basophil phenotypes CIU responders and CIU nonresponders. CIU nonresponder basophils do not degranulate to ex vivo IgE receptor activation and have elevated levels of IgE receptor regulating inhibitor phosphatases, SHIP-1 and SHIP-2. These two phenotypes are independent of autoimmune serum factor and reflect some differences in clinical features. While underlying disease mechanisms are still unclear, available evidence supports basophil responsiveness relevance to urticarial pathogenesis. 6. A, page 576. Histopathologic examination of an urticarial lesion will show pervascular leukocyte infiltrate composed of lymphocytes, eosinophils, neutrophils, and basophils as well as mast cells that have degranulated in the dermis. Neutrophilic predominance on skin lesion biopsy should prompt for evaluation of associated systemic diseases including adult-onset Still disease, Schnitzler syndrome, systemic lupus erythematosus and the hereditary autoinflammatory fever syndromes.

Page 5 of 5 7. C, page 575. In 80% of cases of chronic urticaria where no external allergic cause or other disease process can be identified, the condition is called chronic idiopathic urticarial. Approximately 20% of patients with chronic urticaria have a reproducible physical trigger for their skin lesions (called physical urticarial). 8. B, page 582. There is limited evidence on use of dapsone in chronic urticaria, especially in neutrophilic urticarial. Dapsone is preferred in treatment of urticarial vasculitis, delayed pressure urticarial and angioedema. Patients on dapsone should be monitored for anemia, neuropathy and methemoglobinemia. Other treatments of chronic urticaria that serve as alternative to corticosteroids in antihistamine resistant cases include sulfasalazine, hydroxychloroquine, calcineurin inhibitors, mycophenolate and omalizumab. 9. D, page 582. Muckle-Wells syndrome is associated with mutations in cryopyrin. Patients often have sensorineural hearing loss and are similar to patients with familial cold autoinflammatory syndrome, with the exception that patients are not cold-sensitive. Patients with familial cold autoinflammatory syndrome often present in infancy with symptoms including periodic fever, urticaria, leukocytosis, conjunctivitis and muscle and skin tenderness after exposure to cold. 10. B, page 583, table 36-1. There are two described forms of pressure-related physical urticarial/angioedema. In the first form, urticarial develops shortly after pressure is applied to the skin, similarly to dermatographism. A second delayed-onset form appears several hours after at the site of pressure (in our patient s example, under the waistband of her pants or under the strap of her purse). Skin biopsies from patients with delayed-onset urticarial demonstrate both neutrophils and eosinophils.